Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "Drug Development Technology" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about Drug Development Technology for you to read. Along with our medical data and news we also list Drug Development Technology Clinical Trials, which are updated daily. BioPortfolio also has a large database of Drug Development Technology Companies for you to search.
Japan-based healthcare firm Otsuka Pharmaceutical has secured funding from the Bill & Melinda Gates Foundation to accelerate clinical development of...Read More... The post Otsuka to advance clinical development of anti-TB drug appeared first on Drug Development Technology.
(The Korea Advanced Institute of Science and Technology (KAIST)) A KAIST research team led by Professor Kwang-Hyun Cho of the Department of Bio and Brain Engineering developed technology to find the optimum drug target according to the type of cancer cell. The team used systems biology to analyze molecular network dynamics that reflect genetic mutations in cancer cells and to predict drug response...
Australia Health Minister Greg Hunt has announced new funding to support various organisations in the clinical development of new drugs...Read More... The post New Australian grant to support rare cancer drug development appeared first on Drug Development Technology.
Over the course of 2017, the acute myeloid leukemia (AML) market has experienced dramatic changes with the approval of various...Read More... The post Revived Leukemia drug follows a historical development path in three stages appeared first on Drug Development Technology.
In this programme Fintan Walton talks to Dr Keith Blundy, CEO of Cancer Research Technology, the drug development and commercialisation arm of Cancer Research UK. Having described the relationship between Cancer Research UK and CRT, Dr Blundy goes on to explain that CRT’s role goes beyond drug discovery to source, develop and commercialise drugs in order to achieve their ultimate aim of increasi...
NewsCatalent and Vaccinex, Inc., a clinical-stage biotechnology company, have agreed to develop an antibody-drug conjugate using Catalent’s proprietary SMARTag conjugation platform and GPEx cell line technologies, and Vaccinex’s ActivMAb technology.
Sanofi Chief Medical Officer Dr. Ameet Nathwani expressed excitement about the technology developments that stand to benefit drug development in a fireside chat at StartUp Health
New research from Arizona State University’s (ASU) Biodesign Institute has found that leukaemia drug ibrutinib, marketed by Janssen under the...Read More... The post Leukaemia drug may be repurposed to fight other cancers appeared first on Drug Development Technology.
Tango officially launched in 2017 and hit the ground running as a cancer drug target discovery and drug development company based on CRISPR technology.
The strategic value of BioInvent consists of the patented technology platforms F I R S T™ and n-CoDeR®, as well as considerable expertise in pre-clinical and clinical development and the production of antibody-based drugs. This accumulated competence and know-how serve as the basis of revenue generating contract research and in-house strategic drug development. Michael Oredsson, CEO, BioInvent
AstraZeneca collaborates with Swedish firm Pelago Bioscience to develop assay that increases the speed and efficiency of drug development. Pelago, a Karolinska Institute spin-off, studies the interactions between a drug and its target to make the drug development process faster ... This awesome article AstraZeneca Collaborates With Swedish Biotech To Speed Up Drug Development appeared first on L...
The US Food and Drug Administration (FDA) has released a new graft guidance as part of its stated commitment to assist sponsors and expedite drug development for rare pediatric diseases.
Cancer Research UK’s subsidiary Cancer Research Technology (CRT) has signed a drug discovery collaboration with Celgene for the development and...Read More... The post CRT and Celgene sign drug discovery collaboration appeared first on Pharmaceutical Technology.
NewsUnder the terms of the agreement, Recipharm will co-develop new value added medicines for its customers utilizing patented Intellitab and Flexitab drug delivery technologies from Altus Formulation Inc., a Canadian drug development company.
The EIDD was founded and constructed to provide the multidisciplinary capabilities that are required to effectively advance cutting-edge drug discovery and development programs at the preclinical stage. Fintan Walton, CEO of PharmaVentures interviews Dennis Liotta, Executive Director Emory Institute for Drug Development, Emory College
Provider of, drug discovery, technology, assay, development, genomic data, automation, robotics, toxicology, tutorials, plenary sessions
A recent paper on drug development costs did not impress me. But if possible, it impressed Matthew Herper at Forbes even less. That’s the one where the authors looked at a number of companies that had been around long enough to develop one drug – they figured that this would give a cleaner read on
Dimerix Limited is a clinical stage, biotechnology company that is listed on the Australian Stock Exchange (ASX:DXB). The Company is focused on developing new therapeutics discovered using its proprietary drug development platform, Receptor-Heteromer Investigation Technology (HIT).
A preclinical research finding in mice with tumors treated with checkpoint inhibitors that was first reported in 2015 has now...Read More... The post Could the gut microbiome be the ultimate immuno-oncology drug response biomarker? appeared first on Drug Development Technology.
A new method to predict the physical stability of drug candidates is attracting interest from pharmaceutical companies who could use the technology to de-risk early development.
Biogen is entering neuropsychiatry drug development with a deal to acquire a schizophrenia drug candidate from Pfizer. Cambridge, MA-based Biogen (NASDAQ: BIIB) is paying Pfizer $75 million up front for the drug, PF-04958242. Pfizer (NYSE: PFE) stands to gain as much as $515 million more if the drug hits development and commercialization milestones. If Biogen […]
The race for a cytomegalovirus (CMV) vaccine hit a stumbling block on 22 January, when Astellas and Vical announced that...Read More... The post Cytomegalovirus vaccine continues to elude drug developers appeared first on Drug Development Technology.
NewsPivot Initiated development of its first cannabidiol product with its German technology partner. PGS-N001 is a pure, natural and water-soluble oral cannabidiol (CBD) solution that shows high bioavailability and does not contain THC.
Single-payer system drug price controls would hinder drug development because investors would lose money due to the low succe -More-
CN Bio Innovations and the FDA have entered a research collaboration to better predict drug safety in drug development by using human organs-on-chips. CN Bio Innovations, a spin-out from the University of Oxford, will be working with scientists from the FDA’s ... This awesome article The FDA Recruits British Organs-on-Chips to Speed Up Drug Development appeared first on Labiotech.eu. Be k...